항암화학치료 후 발생한 호중구 감소증에 대한 사물탕가감방 증례 보고

• Published in: 동의생리병리학회지 Vol. 29; no. 1; pp. 85 - 89
• Main Authors: 강휘중(Hwi Joong Kang), 박소정(So Jung Park), 조종관(Chong Kwan Cho), 이연월(Yeon Weol Lee), 유화승(Hwa Seung Yoo)
• Format: Journal Article
• Language: Korean
• Published: 한의병리학회 2015
• Subjects: 한의학; Chemotherapy; Samul-tanggagambang; Absolute Neutrophil Count; Neutropenia
• ISSN: 1738-7698; 2288-2529; 2283-2529
• DOI: 10.15188/kjopp.2015.02.29.1.85

The purpose of this study is to report two patients with neutropenia caused by chemotherapy who prescribed Samul-tanggagambang. Samul-tanggagambang was prescribed three times a day to two patients with chemotherapy induced neutropenia. Complete blood cell count is measured before and after prescription. Absolute Neutrophil Count (ANC) was gradually increased after administration of Samul-tanggagambang to the cancer patients. Significantly, no related adverse events were found. Samul-tanggagambang has shown benefit in improving chemotherapy induced neutropenia. It is expected to be a promising treatment for improving chemotherapy induced neutropenia and more clinical research will be required for evidence based using.